| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bio-Rad Laboratories, Inc. (BIO) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. BIO is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 445.0K | $125.68M | - | |
| VP | 19.8K | $5.58M | - | |
| Pres | 3.5K | $976.1K | - | |
| CFO | 2.4K | $676.1K | - | |
| VP | 2.3K | $650.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2019 | Ernst Timothy S69 | EVP, General Counsel &Sec | Sell | 310 | $320.00 | $99,200.00 | -75.1% | |
| Aug 14, 2019 | Crowley Michael60 | EVP, Gbl Commercial Operations | Sell | 325 | $320.00 | $104,000.00 | -9.5% | |
| May 16, 2019 | Ernst Timothy S69 | EVP, General Counsel &Sec | Sell | 846 | $295.47 | $249,886.82 | -29.9% | |
| Dec 14, 2018 | Tsingos Christine A | EVP And CFO | Sell | 1,411 | $248.00 | $349,928.00 | -17.4% | |
| Dec 14, 2018 | Crowley Michael60 | EVP, Gbl Commercial Operations | Sell | 392 | $248.03 | $97,227.64 | -10.3% | |
| Dec 12, 2018 | Stark James R | VP, Corporate Controller | Sell | 848 | $254.77 | $216,044.96 | -100% | |
| Dec 11, 2018 | Tumolo Annette71 | Executive Vice President | Sale+OE | 2,376 | $254.51 | $604,704.00 | -44.1% | |
| Jun 13, 2018 | Crowley Michael60 | EVP, Gbl Commercial Operations | Sell | 350 | $303.42 | $106,197.14 | -14.0% | |
| Dec 14, 2017 | Tsingos Christine A | EVP And CFO | Sale+OE | 4,980 | $249.40 | $1,242,019.97 | -42.7% | |
| Dec 4, 2017 | Crowley Michael60 | EVP, Gbl Commercial Operations | Sell | 1,000 | $258.39 | $258,394.70 | -28.6% |